Clinical trials are becoming increasingly complex ... Join us for this valuable discussion for key insights into how AI is transforming workflows to help address today’s top data challenges.
AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...
Unveiling the power of AI in patient subgroups SOMS' AI-driven subgroup analysis is transforming clinical trials through real-time data processing and continuous tracking of patient subgroups.
a company advancing the next generation of clinical trials with AI, today announced that it has been awarded the prestigious Participant Engagement Award at the 2025 Summit for Clinical Ops Executives ...
The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe ...
The global AI-based clinical trials solution provider market is poised for remarkable expansion, with its valuation expected to soar from USD 2.2 billion in 2024 to USD 8.7 billion by 2034. This ...
15d
GlobalData on MSNSuvoda introduces AI assistant to manage clinical trialsClinical trial technology company Suvoda has launched the AI assistant Sofia, which helps streamline the process of accessing ...
Summit Therapeutics (SMMT) announced a clinical trial collaboration with Pfizer (PFE) to evaluate ivonescimab, an investigational PD-1 / VEGF bispecific antibody, in combination with several of ...
Powered by Real-World Expertise: Cliniphai has built deep operational experience across clinical studies and is working with trusted partners that have spent decades ensuring linguistic accuracy in ...
MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a clinical trial collaboration with Pfizer Inc. (NYSE: PFE) to evaluate ivonescimab, a novel, investigational PD-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results